Thompson Peter A.

Thompson Peter A. is listed in filings as Director at Sionna Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 29, 2026, including sale activity and purchase activity. Recent filings connect the profile to Sionna Therapeutics, Inc. (SION), Corvus Pharmaceuticals, Inc. (CRVS), ARS Pharmaceuticals, Inc. (SPRY), and Edgewise Therapeutics, Inc. (EWTX). The current snapshot covers public activity from Jun 12, 2024 to May 29, 2026. Reported amounts are shown as $4.5K to $2.7M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.